Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial

Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial

Objective(s): The study objective was to assess the diagnostic performance of positron emission tomography (PET) for gliomas using the novel tracer 18F-fluciclovine (anti-[18F]FACBC) and to evaluate the safety of this tracer in patients with clinically suspected gliomas.Methods: Anti-[18F]FACBC was...

Full description

Bibliographic Details
Main Authors: Toshihiko Wakabayashi, Toshihiko Iuchi, Naohiro Tsuyuguchi, Ryo Nishikawa, Yoshiki Arakawa, Takashi Sasayama, Keisuke Miyake, Tadashi Nariai, Yoshitaka Narita, Naoya Hashimoto, Osamu Okuda, Hiroshi Matsuda, Kazuo Kubota, Kimiteru Ito, Yoichi Nakazato, Kan Kubomura
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2017-01-01
Series:Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:
Clinical trial
18F-fluciclovine
Glioma
Positron emission tomography
Brain tumor
Online Access:http://aojnmb.mums.ac.ir/article_7869_0f71ecbad3a967601365578a7c390741.pdf

Internet

http://aojnmb.mums.ac.ir/article_7869_0f71ecbad3a967601365578a7c390741.pdf

Similar Items